Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: Is it possible to avoid MRD testing?

Leukemia

Volumn 22, Issue 5, 2008, Pages 989-997

  Fronkova, E ^a   Mejstrikova, E ^a   Avigad, S ^b,c   Chik, K W ^d   Castillo, L ^e   Manor, S ^b,c   Reznickova, L ^a   Valova, T ^a   Zdrahalova, K ^a   Hrusak, O ^a   Jabali, Y ^f   Schrappe, M ^g   Conter, V ^h   Izraeli, S ^c,i   Li, C K ^d   Stark, B ^b,c   Stary, J ^a   Trka, J ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e Centro Hospitalario Pereira Rossell   (Uruguay)

^f Regional Hospital   (Czech Republic)

^g UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^h SAN GERARDO HOSPITAL   (Italy)

ⁱ SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; BCR ABL PROTEIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; MERCAPTOPURINE; METHOTREXATE; MIXED LINEAGE LEUKEMIA PROTEIN; PREDNISONE; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR RUNX1; VINCRISTINE;

ACUTE LYMPHOCYTIC LEUKEMIA; AGE; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIPLOIDY; DRUG MEGADOSE; DRUG RESPONSE; HIGH RISK PATIENT; HUMAN; IMMUNOPHENOTYPING; INTERMEDIATE RISK PATIENT; LEUKOCYTE COUNT; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; PATIENT CODING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK; RISK ASSESSMENT;

EID: 43749100248     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.22     Document Type: Article

References (31)